EUVIMEDEUVIMED entdecken
Crossref

Curcumin synergistically augments the chemotherapeutic activity of Doxorubicin in prostate cancer cells

Yalçın Erzurumlu, Deniz Çataklı, Hatice Kübra Doğan

Interdisciplinary Medical Journal · 2024

DOI: 10.17944/interdiscip.1297112 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Interdisciplinary Medical Journal, 2024. Verfasst von Yalçın Erzurumlu und 2 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Suleyman Demirel University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Prostate cancer is one of the most commonly diagnosed cancer types in men and many people die every year due to recurring or acquiring aggressive forms of prostate cancer. Numerous chemotherapeutics such as paclitaxel and doxorubicin are commonly used in the treatment of prostate cancer. However, acquired resistance to chemotherapeutics and broad systemic side effects substantially limit their efficacy. Curcumin is one of the most examined phytochemicals of the herbal remedy turmeric. Herein, we aimed to investigate the synergistic capability of curcumin on doxorubicin in prostate cancer cells.

Method

The human adenocarcinoma cell line LNCaP was used in cell culture studies. Cell viability was examined by WST-1 assay. The protein expression levels of Beclin1, p62/SQSTM1, LC3-I/II, Hrd1, gp78, polyubiquitin, PERK, eIF2, phospho-(Ser51) eIF2, IRE1, XBP-1s, PARP-1, caspase-3, AR, PSA, c-Myc, E-cadherin, N-cadherin and VEGF-A were investigated by immunoblotting assay.

Results

Our data indicated that co-administration of curcumin with doxorubicin significantly improved the cytotoxic effect of doxorubicin in LNCaP cells. Also, the combination of curcumin and doxorubicin reduced the autophagic flux and remarkably induced endoplasmic reticulum-associated-degradation (ERAD) and unfolded protein response (UPR) signaling. Also, activation of apoptotic proteins PARP-1 and caspase-3 were strongly enhanced by combined treatment in a dose-dependent manner. Moreover, combined treatment markedly decreased AR, PSA, c-Myc and VEGF-A levels. Additionally, the epithelial-mesenchymal transition (EMT) was reduced by decreasing N-cadherin and increasing E-cadherin protein levels.

Conclusion

Present data strongly suggest that curcumin synergistically improves the anti-cancer features of doxorubicin in prostate cancer cells.

Förderung

  • Suleyman Demirel University

Zitieren

APA

Erzurumlu, Y., Çataklı, D., & Doğan, H. K. (2024). Curcumin synergistically augments the chemotherapeutic activity of Doxorubicin in prostate cancer cells. Interdisciplinary Medical Journal. https://doi.org/10.17944/interdiscip.1297112

Vancouver

Erzurumlu Y, Çataklı D, Doğan HK. Curcumin synergistically augments the chemotherapeutic activity of Doxorubicin in prostate cancer cells. Interdisciplinary Medical Journal. 2024. doi:10.17944/interdiscip.1297112

BibTeX
@article{Erzurumlu2024,
  author = {Erzurumlu, Yalçın and Çataklı, Deniz and Doğan, Hatice Kübra},
  title = {Curcumin synergistically augments the chemotherapeutic activity of Doxorubicin in prostate cancer cells},
  journal = {Interdisciplinary Medical Journal},
  year = {2024},
  doi = {10.17944/interdiscip.1297112}
}
Kostenlos starten →